Palantir's Growth Has Been Impressive, Its Rule of 40 Score Is Incredible, but This Number Is Just Downright Pitiful

Palantir reported 70% revenue growth last quarter and a 127% Rule of 40 score, but its diluted EPS over the past year was only $0.63, implying a trailing earnings multiple above 200x at roughly $130 per share. The article argues the stock remains expensive despite strong AI-driven growth, noting Palantir is down 25% this year and about 36% below its 52-week high of $207.52. The message is cautionary rather than event-driven, emphasizing valuation risk over operating weakness.

Analysis

The market is starting to separate enterprise AI winners from narrative winners, and that is a direct headwind for highly valued software with weak per-share economics. If growth decelerates even modestly from these levels, the stock’s multiple has little valuation support because the current setup depends on sustained hypergrowth plus continued tolerance for dilution. In that regime, the path of least resistance is lower as long-duration holders de-risk and systematic funds reprice the name on forward EPS rather than revenue.

Second-order, the biggest issue is not business quality but capital intensity hidden inside compensation. Heavy stock issuance creates a structural overhang: even if operating margins stay strong, per-share value creation can lag badly, which makes buybacks or a meaningful slowdown in SBC the only credible catalysts for multiple expansion. That creates a contrast with AI infrastructure beneficiaries like NVDA, where demand is still translating into tangible cash generation and scarcity value rather than just story premium.

The contrarian case is that the stock may already be doing some of the work for bears: sentiment has reset, and any beat-and-raise quarter can squeeze shorts because positioning in premium software often gets crowded only after drawdowns. But that upside is likely tactical, not durable, unless management proves it can convert gross profit into EPS at a much faster rate over the next 2-3 quarters. Without that inflection, rallies should be sold into rather than chased.

Key Decisions for Investors

• Short PLTR on strength into earnings or post-rally extensions; use a 4-8 week horizon and treat 10-15% upside spikes as opportunities to add, since the stock is still trading on narrative rather than durable per-share compounding.
• Prefer a pair trade: long NVDA / short PLTR, targeting a 2-3 month horizon. NVDA benefits from monetized AI capex while PLTR remains exposed to valuation compression if growth normalizes; hedge ratio should overweight the short leg by ~1.2x due to PLTR’s higher multiple risk.
• For options, consider buying PLTR put spreads 1-2 months out rather than outright puts to reduce theta bleed. This works best if implied vol stays elevated while the stock fails to reclaim prior highs.
• If already long PLTR, trim 25-50% on any move back toward prior resistance and re-enter only if the company signals a credible path to lower dilution or meaningful buybacks over the next 2 quarters.
• Monitor SBC and share count as the key catalyst dashboard; if dilution slows materially for two consecutive quarters, the short thesis weakens and the market may rerate the stock 15-20% higher on EPS optics alone.